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A B S T R A C T
The aim of the study was to assess the relationship between systolic blood pressure during maximal treadmill test
(SBPmtt) and flow-mediated vasodilation (FMD). Abnormal rise of SBPmtt is the phenomenon more frequent in hyperten-
sive persons but it could be found in normotensive subjects too. 199 subjects referred to treadmill test were enrolled in the
study. Four groups were formed: hypertensives with abnormal SBPmtt (group A), hypertensives with normal SBPmtt
(group B), normotensives with abnormal SBPmtt (group C) and normotensives with normal SBPmtt (group D). Rise of
SBPmtt above 200 mmHg was considered abnormal reaction. Simple linear regression analysis showed significant in-
verse relationship between SBPmtt and FMD (F=20.2036, p<0.001, R
2=0.0956). Mean FMD index was worst in hyper-
tensive subjects with abnormal SBPmtt (group A), followed by normotensives with abnormal SBPmtt (group C), hyper-
tensives with normal SBPmtt (group B) and the best was in normotensives with normal SBPmtt (3.56±5.17, 4.19±5.14,
6.81±8.43 and 10.92±7.48%, respectively). In multivariate regression analysis FMD showed significant association
with abnormal SBPmtt (p<0.001) along with brachial artery diameter (p<0.001), male gender (p<0.001), but not with
hypertension (p=0.073), BMI (p=0.137) and total cholesterol (p=0.23) (coefficients: –0.26, –0.40, –0.27, –0.13, –0.11 and
–0.07, respectively). There was a significant inverse relationship between SBPmtt and FMD. An impairment of FMD ex-
ists in normotensive subjects with abnormal SBPmtt. In hypertensives with abnormal SBPmtt an additional impairment
of FMD exists when compared to hypertensives with normal SBPmtt. Abnormal SBPmtt should be taken into account in
global cardiovascular risk assessment.
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Introduction
A physiologic reaction during exercise comprises of
progressive increase in systolic blood pressure (SBP),
mean blood pressure and pulse pressure. Diastolic blood
pressure during exercise shows little variation; it either
slowly elevates, maintains the same level or slowly de-
creases, especially in younger subjects1. The systolic blo-
od pressure during maximal treadmill test (SBPmtt) is
higher among men2, and African Americans show higher
rise in SBPmtt than Caucasians3. Trained subjects with
higher maximal work capacities react to exercise with
smaller increase of systolic blood pressure4 and with
lower heart rate5.
Some subjects experience abnormal rise in SBP dur-
ing exercise. This phenomenon expresses variability of
blood pressure reaction to exercise, as an example of bio-
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logical diversity and is probably related to genetic fac-
tors6. Abnormal rise in SBP during exercise test is not a
rare phenomenon. It is more frequent in hypertensive
subjects but could be also found in normotensive sub-
jects7. Some authors consider SBP above 200 mmHg as
abnormal reaction to exercise, while others take the
cut-off at 220 mmHg8. Unfortunately, there is no consen-
sus on the cut-off value of SBPmtt8. Relationship between
cardiovascular morbidity and mortality and SBPmtt, as
an additional risk factor, was found in several studies9–11.
On the other hand, FMD as a marker of endothelial dys-
function is decreased in the presence of all traditional
major risk factors for cardiovascular diseases12–15.
The aim of this study was to determine the relation-
ship between SBPmtt achieved during maximal treadmill
test and brachial artery flow-mediated vasodilatation
(FMD) as an index of endothelial function. The second
aim was to assess whether normotensive subjects with
abnormal SBPmtt differ from normotensive subjects with
normal rise in SBPmtt regarding to FMD as well as hyper-
tensive subjects with abnormal SBPmtt to hypertensive
subjects with normal rise in SBPmtt.
Subjects and Methods
Subjects who were referred to treadmill test in Cardio-
vascular department Clinical Hospital Dubrava during pe-
riod February 2002 and April 2003 were enrolled in this
study. All subjects were Caucasians. Exclusion criteria in-
cluded history of myocardial infarction, valvular heart dis-
ease, secondary hypertension, any endocrine, respiratory
or kidney disease, and any acute disease. All subjects had
given informed consent to participate in the study, which
was approved by the local ethical committee.
All subjects were asked for details in their medical
history and had a brief cardiovascular examination to ex-
clude symptomatic cardiovascular disease and to assess
their cardiovascular risk factors. All subjects had blood
pressure and pulse measured after at least 10 minutes of
rest in the supine position. Hypertension was defined as
resting diastolic blood pressure (DBP) over 90 mmHg or
systolic blood pressure over 140 mmHg. In all subjects
total serum cholesterol was also measured. Only mild hy-
pertensive subjects with SBP between 140–159 mmHg
and DBP between 90–99 mmHg were included in the
study. Subjects with moderate and severe hypertension
having a risk related to possible drug therapy interrup-
tion were not included. Subjects on antihypertensive
medication were asked to withhold it for at least 48 hours
before brachial artery vascular reactivity measurements
was performed.
Exercise test
Exercise test was performed on a treadmill Marquette
Hellige Medical system according to Bruce protocol. Dur-
ing exercise the subjects were under continuous ECG
monitoring. Blood pressure was measured with mercury
sphygmomanometer every 3 minutes at the end of every
step. If SBP higher than 200 mmHg was reached, test
was stopped and the subject was considered to have an
abnormal SBPmtt reaction.
Brachial artery vascular reactivity measurements
Endothelial function was assessed non-invasively by
measuring endothelium-dependent dilation. High-reso-
lution external ultrasound (7 MHz compact linear ultra-
sound transducer ATL HDI 3000) was used to measure
changes in brachial artery diameter in response to reac-
tive hyperemia and in response to glyceryltrinitrate. The
subject’s right arm was comfortably immobilized in the
extended position to allow consistent imaging of the
brachial artery. After an initial 10 minutes rest in the su-
pine position, baseline recordings of brachial artery di-
ameter and flow velocity were performed. The right
brachial artery was scanned in longitudinal sections of
2–15 cm above the elbow (control scan). Depth and gain
settings were optimized to identify the vessel wall to lu-
men interface, and a resting scan recorder. The distance
from the antecubital crease was noted and the following
examinations were all performed in the same position.
Diameter measurements were taken at end-diastole, co-
incident with R-wave on the continuously recorded elec-
trocardiography trace. The brachial artery diameter was
measured using the leading edge of the near wall to the
leading edge of the far wall of the artery along a line per-
pendicular to the artery’s long axis using an electronic
caliper. Diameter changes were expressed as the percent-
age change relative to the mean baseline scan (100%).
Reactive hyperemia was induced by inflation and then
deflation of standard sphygmomanometer cuff placed
around the forearm (below the scanned part of the ar-
tery), inflated to approximately 200 mmHg for 5 min.
The artery was scanned prior to cuff inflation and for 90
seconds after cuff deflation. Hyperemia was calculated as
the ratio of the post deflation flow to the resting flow
value. Arterial flow velocity measurements were obtain-
ed using a pulsed Doppler at 60° to the vessel with range
gate (1.5 mm) in the center of the artery. Volume flow
was measured during rest as well as during the peak re-
sponse of the maximum flow in a single cardiac cycle dur-
ing the 10–20 second periods after cuff release. After at
least 10 minutes rest, a further control scan was re-
corded and finally 400 mg of glyceryltrinitrate spray was
administered sublingually. The final scan was performed
3 min after glyceryltrinitrate. Images were recorded on
videotape for subsequent off-line analysis on the same
instrument16.
Statistical analysis
According to the maximal systolic blood pressure re-
corded during treadmill test, 4 groups were formed: hy-
pertensive subjects with abnormal SBPmtt (group A), hy-
pertensive subjects with normal SBPmtt (group B),
normotensive subjects with abnormal SBPmtt (group C) and
normotensive subjects with normal SBPmtt (group D).
Group’s characteristics were analyzed with ANOVA test.
Relationship between SBPmtt and FMD was analyzed by
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linear regression analysis. Forward stepwise multiple re-
gression analysis was used to investigate the contribution
of available predictor variables to the FMD. Only p values
<0.05 were considered statistically significant.
Results
A consecutive sample of 199 subjects (116 men, 83
women, median age 52.5, range 23–71 years) was en-
rolled in this study. Baseline characteristics of all groups
of subjects are shown in Table 1.
Linear regression analysis showed a significant in-
verse relationship between SBPmtt and FMD in all sub-
jects (F=20.20, p<0.001, R2=0.0956) (Figure1). More-
over, in the group of normotensive subjects (group C and
D combined) a significant relationship was found be-
tween SBPmtt and FMD by linear regression analysis
(F=8.57, p=0.004, R2=0.086), but not in the subgroup of
hypertensive subjects (group A and B combined)
(F=1.01, p=0.316, R2=0.01). In normotensive subjects
(group C and D combined) FMD was higher than in hy-
pertensive subjects (group A and B combined)
(7.45±6.25 vs. 4.51±4.84; p<0.01). In hypertensive sub-
jects with abnormal SBPmtt (group A), FMD was worst
followed by normotensive subjects with abnormal SBPmtt
(group C), hypertensive subjects with normal SBPmtt
(group B) and, at last, normotensive subjects with nor-
mal SBPmtt (3.56±5.17, 4.19±5.14, 6.81±8.43 and
10.92±7.48%, respectively; p<0.001) (Figure 2).
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TABLE 1
DEMOGRAPHIC CHARACTERISTICS AND ATHEROSCLEROSIS RISK FACTORS IN THE FOUR GROUPS
Group A Group B Group C Group D F p
Number of subjects 57 46 43 53
Age (years), X±SD 53.84±8.60 53.89±8.47 51.88±11.53 49.32±11.12 1.83 0.142
Male/female, N:N (%) 31:26 (54.39%) 31:15 (67.39%) 25:18 (58.14%) 29:24 (54.72%) 1.25 0.291
Weight (kg), X±SD 86.07±14.60 80.54±14.30 83.74±13.02 77.64±17.60 5.21 0.002
Hight (cm), X±SD 169.23±8.63 170.84±8.31 173.58±8.85 172.49±11.12 3.66 0.013
BMI (kg/m2), X±SD 29.93±3.77 27.54±3,73 27.74±3.31 25.82±3.83 12.99 0.000
Diameter of brachial artery (mm), X±SD 43.57±8.09 40.69±6.03 43.46±6.72 38.53±7.52 8.33 0.000
Colesterol (mg/dL), X±SD 5.99±1.10 5.96±1.14 6.08±1.07 5.96±1.07 1.73 0.160
Current smokers, N (%) 12 (21.05%) 7 (15.22%) 15 (34.88%) 12 (22.64%) 1.86 0.136
SBPr (mmHg) 155±13 (130–190) 142±17 (105–170) 143±12 (120–170) 126±14 (100–180) 37.99 0.000
DBPr (mmHg) 98±9 (80–120) 91±12 (60–115) 90±7 (75–105) 82±10 (65110) 24.02 0.000
Antihypertensive therapy 57 46 0 0
GTN dilatation (%) 8.76±8.99 17.83±10.24 12.50±7.70 23.60±12.57
BMI – body mass index, SBPr – systolic blood pressure at rest, DBPr – diastolic blood pressure at rest, SD – standard deviation, GTN –
glyceryltrinitrate
Fig 1. Relationship between FMD and SBPmtt in all subjects. The solid central line is the standard linear regression line. The dashed
lines represent 2 standard deviations from the mean (95% confidence interval), R2=0.0956, p<0.001.
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Multivariate regression analysis showed a significant
association between FMD and abnormal SBPmtt (p<0.001),
along with brachial artery diameter (p<0.001), male gen-
der (p<0.001), but not with hypertension (p=0.073), BMI
(p=0.137) and total serum cholesterol (p=0.23) (Table 2).
Discussion
Arterial blood pressure during exercise differs from
the resting values. SBP increases in relation to exercise.
There is a linear relationship between SBP, increased
workload and heart rate during exercise. Arterial hyper-
tension as a cardiovascular risk factor refers to the blood
pressure values in resting. Some investigators have sug-
gested that exercise blood pressure measurement gives
additional information in cardiovascular risk assessment
due to higher mortality among subjects with abnormal
systolic blood pressure at exercise (SBPmtt)9–11.
Investigation of FMD offeres new, noninvasive and re-
producible method for assessment of endothelial func-
tion. Reduced FMD was found in the presence of all ma-
jor risk factors for cardiovascular diseases12–15. Systolic
blood pressure hyper-reactivity during exercise decre-
ases the ability of vessel wall diameter to increase in rela-
tion to increased flow. We found a statistically significant
relationship between SBPmtt and FMD. In subjects with
lower SBPmtt, the FMD was higher, and in patients with
higher SBPmtt FMD showed minimal changes, indicating
that subjects with abnormal SBPmtt are likely to have en-
dothelial dysfunction.
Hypertensive subjects have increased blood pressure
at rest, but during exercise some had normal SBPmtt. Low-
er FMD was found in this subject group, and our results
show consistency with reported findings of other au-
tors17. Relationship between FMD and SBPmtt in hyper-
tensive subjects was not statistically significant in this
study, in contrast to findings among normotensive sub-
jects. Increased change in diameter of brachial artery in
relation to increased flow was higher in normotensive
group in comparison with hypertensives. Hypertensive
subjects have poorer ability to increase vessel wall diam-
eter in response to flow. Thus, hypertensive subjects
have decreased endothelial function regardless of whe-
ther they do have abnormal SBPmtt or not.
Hypertensive subjects with abnormal SBPmtt were not
studied concerning endothelial dysfunction as a sub-
group. This study showed that they had the worst FMD
value and thus they are at the highest risk of developing
atherosclerosis and consequent cardiovascular diseases.
Their ability to change diameter to the flow is minimal in
comparison with other groups.
Hypertensive subjects with normal SBPmtt were in-
cluded in hypertensive group in previous studies and
were not studied as a subgroup considering endothelial
dysfunction. In this study their FMD (6.81±8.43%) was
better when compared with all hypertensive subjects
(group A and B combined; 4.19±5.14%, p<0.05) and partic-
ularly with hypertensive subjects with abnormal SBPmtt
(group A 3.56±5.17%, p<0.01). Thus, hypertensive sub-
jects with normal SBPmtt have better endothelial func-
tion than hypertensive subjects with abnormal SBPmtt.
Surprisingly, their FMD is even better then FMD in
normotensive subjects with abnormal SBPmtt (4.19±5.14%,
p<0.05). The greater percentage of women in group B
and smokers in group C is not statistically significant to
explain the difference of FMD found between these two
groups.
In normotensive subjects with normal SBPmtt the ex-
pected normal value of FMD was found, but it was better
than FMD in all normotensive subjects. Hence, this
group of normotensives has a higher vascular reactivity
to stress than any other group as well as the best endo-
thelial function.
Normotensives with abnormal SBPmtt (group C), in
previous studies were included among normotensive sub-
jects (C and D groups combined) and were not studied as
a subgroup concerning their endothelial function. We
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Fig 2. Flow-mediated dilatation (FMD) and glyceryltrinitrate di-
latation (GTN) in hypertensive subjects with abnormal SBPmtt
(group A), hypertensive subjects with normal SBPmtt (group B),
normotensive subjects with abnormal SBPmtt (group C), normo-
tensive subjects with normal SBPmtt (group D).
TABLE 2
MULTIVARIATE REGRESSION ANALYSIS WITH FMD
AS DEPENDENT VARIABLE
Predictor variable
Standardized regression
coefficient
p value
Abnormal SBPmtt –0.26 <0.001
Brachial artery diameter –0.40 <0.001
Male gender 0.27 <0.001
Hypertension –0.13 0.073
BMI 0.11 0.137
Total cholesterol –0.07 0.23
SBPmtt – systolic blood pressure during maximal treadmill test,
BMI – body mass index
U:\coll-antropolo\coll-antro-2-2007\Mirat-7094.vp
18. svibanj 2007 13:57:16
Color profile: Disabled
Composite  150 lpi at 45 degrees
found low values of FMD (4.19±5.14%) in this group.
This was an unexpected result for normotensive sub-
jects. Even more, they showed lower FMD mean value
than hypertensive subjects with normal SBPmtt. Our data
show that the normotensive subjects with abnormal SBPmtt
have worst impairment of endothelial function than hy-
pertensive subjects with normal SBPmtt. Normotensive
subjects with abnormal SBPmtt have also impaired endo-
thelial function, and according to our data they should be
at higher risk for atherosclerosis development than hy-
pertensive subjects with normal SBPmtt.
The subjects with abnormal SBPmtt are more often hy-
pertensive but they could be normotensive too6. In general
population the prevalence of hypertensive persons is
smaller than normotensive persons. Thus, in absolute
numbers in general population normotensive persons
with abnormal SBPmtt may prevail over hypertensive per-
sons with abnormal SBPmtt. Therefore, we should pay
more attention to these subjects concerning the risk strat-
ification for atherosclerosis. It can be speculated if they
are future hypertensives and if they should be treated, al-
though they have normal blood pressure values at rest.
The present study has several limitations. Firstly,
only persons with mild hypertension were included in
the study. Those with moderate and severe hypertension
were excluded because of potential risk of treatment in-
terruption. This may limit the application of the results
to a general population of hypertensive persons. Sec-
ondly, except for hypertension, other risk factors were
not taken into the consideration. This could have intro-
duced confounding effect. Given these limitations, the
study requires further validation in a different popula-
tion. Anyhow, the study demonstrates a significant rela-
tionship between SBPmtt and FMD and stresses potential
importance of SBPmtt in cardiovascular risk assessment.
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ABNORMALNI SISTOLI^KI KRVNI TLAK U TESTU OPTERE]ENJA I POREME]AJ O PROTOKU
OVISNE DILATACIJE BRAHIJALNE ARTERIJE
S A @ E T A K
Cilj ovog istra`ivanja bio je utvrditi odnos izme|u sistoli~kog krvnog tlaka za vrijeme maksimalnog testa optere}enja
i o protoku ovisne dilatacije. Pretjerani porast SKTmtt je fenomen ~est u hipertoni~ara ali se mo`e pojaviti i kod nor-
motoni~ara tako|er. U ispitivanje smo uklju~ili 199 ispitanika. Formirane su ~etiri grupe: hipertoni~ari s abnormalnim
porastom SKTmtt (Grupa A), hipertoni~ari s normalnim porastom SKTmtt (grupa B), normotoni~ari s abnormalnim
porastom SKTmtt (Grupa C) i normotoni~ari s normalnim porastom SKTmtt (Grupa D). Porast SKTmtt preko 200 mmHg
smatrao se abnormalan. Jednostavnom linearnom regresijskom analizom na|ena je statisti~ki zna~ajna negativna ovis-
nost izme|u SKTmtt i FMD (F=20.2036, p<0.001, R2=0.0956). Srednja vrijednost indeksa FMD u pojediniom grupama
bila je najni`a u hipertoni~ara s abnormalnim porasto SKTmtt (3.56±5.17) (Grupa A), izad njih su bili normotoni~ari s
abnormalnim vrijednostima SKTmtt (4.19±5.14) (Grupa B), zatim hipertoni~ari s normalnim vrijednostima SKTmtt
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(6.81±8.43) (Grupa C) i najvi{e vrijednosti su postignute u normotoni~ara s normalnim porastom SKTmtt 10.92±7.48
(Grupa D). Multivarijatnom regresijskom analizom FMD je pokazao zna~ajnu povezanost s abnormalnim SKTmtt
(p<0.001) koju su slijedili dijametar brahijalne arterije (p<0.001), spol (p<0.001) ali ne i hipertenzija (p=0.073), BMI
(p=0.137) i ukupni kolesterol (p=0.23). O{te}enje FMD postoji u normotoni~ara s abnormalnim SKTmtt. U hiperto-
ni~ara s abnormalnim SKTmtt postoji dodatno o{te}enje FMD u odnosu na hipertoni~are s normalnim SKTmtt. Ab-
normalan SKTmtt bi se trebao uzeti u obzir u globalnoj procijeni kardiovaskularnog rizika.
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